Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial

Autor: Saad, Fred, Cella, David, Basch, Ethan, Hadaschik, Boris A, Mainwaring, Paul N, Oudard, Stéphane, Graff, Julie N, McQuarrie, Kelly, Li, Susan, Hudgens, Stacie, Lawson, Joe, Lopez-Gitlitz, Angela, Yu, Margaret K, Smith, Matthew R, Small, Eric J
Zdroj: In The Lancet Oncology October 2018 19(10):1404-1416
Databáze: ScienceDirect